Ethocybin

Ethocybin (also known as CEY-19 and Cyanescens ethocybin) is a psychedelic and entheogenic alkaloid of the tryptamine class. It is found in certain species of Psilocybe, a genus of mushrooms, specifically Psilocybe cyanescens. Ethocybin was first isolated from these mushrooms by chemists at Sandoz in the 1960s.

Chemistry

Ethocybin is a member of the tryptamine class of alkaloids, which also includes other psychedelic substances such as psilocybin, psilocin, and DMT. It is structurally similar to psilocybin, with the only difference being the ethyl group in ethocybin instead of the methyl group in psilocybin. This structural similarity is responsible for the similar psychedelic effects of the two substances.

Pharmacology

Like other tryptamines, ethocybin acts primarily as a serotonin receptor agonist. It is thought to affect the 5-HT2A receptor, which is involved in regulating mood, anxiety, and perception. The exact mechanism of action is not fully understood, but it is believed to involve a complex interplay of neurochemical and psychological processes.

Effects

The effects of ethocybin are similar to those of other psychedelic tryptamines. They can include visual and auditory hallucinations, changes in perception of time and space, altered thought processes, and heightened emotional sensitivity. The intensity and duration of these effects can vary depending on the dose and individual's physiology and psychology.

Legal Status

The legal status of ethocybin varies by country. In many places, it is classified as a Schedule I drug, meaning it is considered to have a high potential for abuse and no accepted medical use. However, research into the potential therapeutic uses of ethocybin and other psychedelics is ongoing.

See Also

• Psilocybin
• Psilocin
• DMT
• Psychedelic therapy